# Alphabet's Isomorphic Labs raises $5B to accelerate drug discovery with AI

DevFeed: [Alphabet's Isomorphic Labs raises $5B to accelerate drug discovery with AI](<https://devfeed.tech/articles/alphabet-s-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai-139215.md>)

Original publisher: [Read original article](<https://siliconangle.com/2026/11/17/alphabets-isomorphic-labs-raises-5b-to-accelerate-drug-discovery-with-ai/>)

Author: Maria Deutscher

Published: 2026-11-17T23:51:11Z

Content type: news

Language: en

Sources: [SiliconANGLE](<https://devfeed.tech/sources/siliconangle.md>)

Topics: [AI for science](<https://devfeed.tech/topics/ai-for-science.md>), [Artificial Intelligence](<https://devfeed.tech/topics/ai.md>)

Tags: [ai](<https://devfeed.tech/tags/ai.md>), [algorithms](<https://devfeed.tech/tags/algorithms.md>), [alphabet](<https://devfeed.tech/tags/alphabet.md>), [biology](<https://devfeed.tech/tags/biology.md>), [clinical-trials](<https://devfeed.tech/tags/clinical-trials.md>), [drug-discovery](<https://devfeed.tech/tags/drug-discovery.md>), [funding-round](<https://devfeed.tech/tags/funding-round.md>), [google](<https://devfeed.tech/tags/google.md>), [investment](<https://devfeed.tech/tags/investment.md>), [isodde](<https://devfeed.tech/tags/isodde.md>), [isomorphic-labs](<https://devfeed.tech/tags/isomorphic-labs.md>), [news](<https://devfeed.tech/tags/news.md>), [the-latest](<https://devfeed.tech/tags/the-latest.md>)

## AI overview

Isomorphic Labs closed a $5 billion investment led by Greenoaks and Sequoia Capital, with Alphabet also making a "significant investment" through GV and CapitalG. Its IsoDDE platform is used by multiple pharmaceutical companies, according to the company, to speed drug discovery tasks. The article says IsoDDE helps identify protein binding pockets or develop compounds that induce them. It also says the platform skips the crystallization and X-ray scanning used to create 3D protein models for FEP algorithms, which can be hardware-intensive and costly, and that IsoDDE produces higher-quality output; these are Isomorphic's claims. CEO Demis Hassabis said the funding would support foundational biology models, disease understanding, and therapeutic programs moving toward clinical trials. The company also plans to build bioengineering infrastructure and expand its partner ecosystem.

## Source excerpt

Isomorphic Labs Ltd. today announced that it has closed a $5 billion investment led by Greenoaks and Sequoia Capital. The venture capital firms were joined by more than a half-dozen other backers. The group included Isomorphic parent Alphabet Inc., which made a "significant investment." The search giant provided the capital through its GV and CapitalG startup [...] The post Alphabet's Isomorphic Labs raises $5B to accelerate drug discovery with AI appeared first on SiliconANGLE.